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1. Introduction 
The 5’-terminus of tobacco mosaic virus (TMV) 
RNA, long thought to be an unphosphorylated A 
residue [ 1,2], was recently identified as m7GS’pppS’Gp 
[3,4]. The assembly reaction of TMV RNA with TMV 
protein is thought to start at the 5’ end and proceed 
to the 3’ end along the RNA chain [5-71. It would be 
interesting to know whether the odd structure at 
the 5’-terminus is related to the assembly reaction. 
On the other hand, elimination of the 3’-terminal 
base of TMV RNA by a chemical procedure (periodate 
oxidation and subsequent cleavage by aniline) was 
reported to cause marked loss of infectivity [8]. How- 
ever, this chemical procedure probably eliminated 
both the 5’ and 3’ end of TMV RNA, so it is uncertain 
which elimination reaction was responsible for loss of 
infectivity. ’ 
These considerations prompted us to investigate the 
removal of the 5’-terminal blocked structure of TMV 
RNA and its effects on the assembly reaction and 
infectivity. Recently, a novel phosphodiesterase was 
purified from cultured tobacco cells [9]. This enzyme 
released pm7G from the 5’-terminal blocked structure 
of cytoplasmic polyhedrosis virus mRNA, but did not 
attack the polynucleotide chain of the mRNA [lo]. 
We used this enzyme to digest TMV RNA. We found 
that it preferentially cleaved the 5’-blocked structure 
of TMV RNA and that TMV RNA lacking the 5’- 
blocked structure showed unchanged ability to 
assemble with the coat protein, but no infectivity. 
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2. Materials and methods 
TMV RNA and protein were prepared from 
purified TMV (Japanese common strain OM) by the 
acetic acid method [ 1 I] and extraction with phenol- 
bentonite [ 121, respectively. 
TMV RNA labeled with tritium at both termini 
was prepared by periodate oxidation and subsequent 
reduction with tritium labeled sodium borohydride, 
as described before [5]. On this treatment, the base 
moiety of m’G, and the ribosyl residues of the 3’ and 
5’ ends, were all reduced with tritium borohydride. 
However, 7-methyl-8-hydro [ 3H]guanosine was 
reoxidized very quickly in aqueous solution [ 131, and 
the C-8 tritium proton of m’G rapidly exchanged 
with a proton of the solvent [ 141. Analysis by phos- 
phocellulose (P-cellulose) column chromatography 
after digestion of tritium labeled TMV RNA with 
ribonuclease T2 showed that about half the radio- 
activity was present as m’G’pppCp, arising from the 
5’-terminal structure, and the other half as A’, derived 
from the 3’-terminus (A’ and G’ represent the nucleo- 
side trialcohols of A and G, respectively, as described 
RajBhandary [15]). 
Tobacco phosphodiesterase was purified from 
cultured tobacco cells. The purification procedure is 
described elsewhere [9]. The enzyme was incubated 
with substrate at 30°C in 0.05 M sodium acetate 
buffer (pH 5.9) containing 1 mM EDTA [IO] and the 
products were analysed by column chromatography 
on Dowex 1 [ 161 and on P-cellulose [17]. 
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Experiments on reconstitution of TMV were 
performed by the method of Fraenkel-Conrat and 
Singer [ 181 except that TMV protein was preincubated 
in 0.1 M phosphate buffer (pH 7.2) at 20°C for 24 h. 
The infectivity of the preparations was assayed on 
Nicotiana tabacum var. Xanthi nc by the half-leaf 
comparison method. 
3. Results 
3.1. Enzymatic removal of the 5’-terminal blocked 
structure of tritium-labeled TMV RNA 
When tobacco phosphodiesterase was incubated 
with tritium-labeled TMV RNA about 50% of the 
radioactivity was released into the acid-soluble 
fraction. This fractions was analysed by Dowex 1 
column chromatography (fig.1). The radioactivity 
was eluted in two fractions: one in the void volume 
(peak I) and the other in the position close to CMP 
(peak 11). On P-cellulose column chromatography 
peak I was eluted in a position very close to pm7G 
(fig.2, A) and in the same position of m7G’ after diges- 
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Fig.1. Dowex 1 X 2 column chromatography of cleavage 
products formed by incubation of ‘H-labeled TMV RNA 
with tobacco phosphodiesterase. 3H-labeled TMV RNA (10 kg) 
was incubated with the enzyme (0.07 units) at 30°C for 
10 min under the standard condition and then the mixture 
was applied to a column (0.5 X 20 cm) of Dowex 1 X 2. The 
column was washed with water and then eluted from tube 
number 10 with a linear gradient of 0.005 N HCl to 0.01 N 
HCl + 0.1 M NaCl. pm’G, CMP and 2’,3’AMP were included 
as internal markers. (i)) Absorbance at 260 nm, (0) radio- 
activity. 
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Fig.2. Analysis of cleavage products of TMV RNA on digestion 
with tobacco phosphodiesterase by column chromatography 
on phosphoccllulose. (A); Peak I in fig.1 was directly applied 
to a column (0.9 X 35 cm) of phosphocellulose equilibrated 
with 10 mM HCOONH, (pH 3.85). The column was washed 
with the same buffer and then eluted with a linear gradient 
of 10 mM to 0.4 M HCOONH, (pH 3.85). (B), (0; Peak I 
(B) or peak II (C) in fig.1 was incubated with bacterial alkaline 
phosphatase (0.2 units) in 0.1 M Tris-HCl (pH 7.8) containing 
0.1 mM MgCl, at 37°C for 2 h, and then the mixture was 
analyzed. (u) Absorbance at 260 nm, (0) radioactivity. 
tion with bacterial alkaline phosphatase (fig.2, B). 
Digestion of peak 11 with alkaline phosphatase yielded 
only one product which was eluted in the same 
position as m7G’ from a P-cellulose column (fig.2, C). 
Scarcely any radioactivity in the acid-soluble fraction, 
corresponded to pA’ or A’. These results indicate that 
the 5’-terminal blocked structure of tritium labeled 
TMV RNA was quantitatively digested with tobacco 
phosphodiesterase and released as pm7G’ and ppm7G’. 
By the prolonged digestion ppm7G’ was converted 
into pm7G’ (data not shown). 
To see whether the phosphodiester bond of TMV 
210 
Volume 67, number 2 FEBS LETTERS August 1976 
FRACTION NUMBER 
Fig.3. Sucrose density gradient analysis of ‘H-labeled TMV 
RNA after incubation with tobacco phosphodiesterase. 
‘H-labeled TMV RNA was incubated with (B) or without 
(A) the enzyme under the conditions described in the legend 
to fig.1. The RNA was analyzed by centrifugation at 
22 000 rev/min in a S-20% sucrose gradient in 10 mM Tris- 
HCI buffer (pH 7.4) for 18 h at 4°C in a SW-25-1 swinging 
bucket rotor of a Hitachi ultracentrifuge. The radioactivity 
in aliquots of the fractions was counted. Sedimentation is 
from right to left. 
RNA was digested by tobacco phosphodiesterase, 
tritium-labeled TMV RNA was incubated with the 
enzyme and then the mixture was directly analysed 
by sucrose density gradient centrifugation. Approxi- 
mately half the radioactivity was recovered at the top 
of the gradient while the other half was found in the 
position of intact TMV RNA (fig.3). Digestion of 
TMV RNA with tobacco phosphodiesterase caused no 
change in the size of RNA. 
3.2. Assembly of TMVprotein with TMV RNA 
lacking the 5’-terminal blocked structure 
A mixture of native TMV RNA and tritium-labeled 
TMV RNA, was digested with tobacco phospho- 
diesterase. The reaction mixture was then incubated 
with TMV protein under the conditions for the 
reconstitution reaction, and analysed by sucrose 
density gradient centrifugation. As a control, undigested 
TMV RNA was incubated with TMV protein and 
analysed in the same way. As shown in fig.4, the 
amount of reconstituted particles formed from phos- 
phodiesterase-treated TMV RNA was almost equal to 
that formed from untreated TMV RNA, although 
the specific radioactivity of these reconstituted 
particles was about a half that of the control particles 
formed from untreated TMV RNA. Radioactive 
pm7G’pppCp and A’ were both identified in alkaline 
digests of the control particles whereas only radio- 
active A’ was found in the digest of particles formed 
from enzyme treated TMV RNA (data not shown). 
From these results, it was concluded that TMV RNA 
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Fig.4. Sucrose density gradient analysis of the particles 
reconstituted from TMV protein and TMV RNA treated 
(B) or not treated (A) with tobacco phosphodiesterase. 
Native TMV RNA containing ‘H-labeled TMV RNA was 
treated with the enzyme as described in the legend to fig.1, 
and then incubated with 30-fold excess of TMV protein in 
0.1 M sodium phosphate buffer (pH 7.2) at 25°C for 
60 min. The reaction mixture was analyzed by centrifugation 
at 24 000 rev/min on a S-20% sucrose gradient in 10 mM 
phosphate buffer (pH 7.2) for 2 h at 4°C. Sedimentation 
is from right to left. (o) Absorbance at 260 nm, (0) radio- 
activity. 
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Table 1 
Infectivity of TMV RNA lacking the 5’-terminal blocked 
structure 
Lesions per half-leaf 
RNA Reconstitution mixture 
Enzyme treatment + - + 
No. of leaves 
1. 7 592 11 470 
2. 1 487 3 4.56 
3. 5 375 3 324 
4. 0 231 3 188 
5. 0 176 
TMV RNA lacking the 5’-terminal blocked structure and its 
reconstituted complex with TMV protein were prepared as 
described in the legend to fig.4 and their infectivities were 
assayed at concentrations of native RNA of 1.57 Mg/ml and 
1.14 X 10-s ug/ml, respectively. 
lacking the 5’-terminal blocked structure assembled 
with coat protein as well as native TMV RNA. 
3.3. Infectivity of TMV RNA lacking the 5’-terminal 
blocked structure 
The infectivity of TMV RNA which had been 
treated with tobacco phosphodiesterase was assayed 
on tobacco plants as free RNA or after reconstitution 
with TMV protein. As shown in table 1, TMV RNA 
lost its infectivity almost completely on removal of 
the 5’-terminal blocked structure. 
4. Discussion 
In this work it was found that tobacco phospho- 
diesterase cleaved tritium labeled TMV RNA releasing 
pm’G’ and ppm’G’. Results indicated that the enzyme 
preferentially cleaved the pyrophosphate bond of the 
5’-terminal methylated blocked structure of TMV RNA, 
even when the terminal nucleoside was modified to a 
nucleoside dialcohol derivative by periodate oxidation 
and subsequent reduction with borohydride. 
It has been thought that reconstitution of TMV 
starts at the 5’:end of the RNA [5-71. However, the 
present work showed that, the 5’-terminal blocking 
structure of TMV RNA is not necessary for initiation 
of the reconstitution reaction. Previously we found 
that almost all of the radioactivity of partially recon- 
stituted RNA prepared from tritium labeled TMV 
RNA was liberated into the acid-soluble fraction on 
digestion with ribonuclease [5]. This indicates that the 
5’ and 3’ ends of partially reconstituted RNA are both 
attacked by ribonuclease, at least, during the early 
stage of the reconstitution reaction. That is, assembly 
does not seem to start from the 5’ end of TMV RNA, 
although it may start close to the 5’ end. The present 
results support this idea. 
TMV RNA lacking the 5’-terminal blocking structure 
has no infectivity, although the biological meaning of 
the removal of the blocking structure is not clear yet. 
This is the first report of direct evidence that the 
blocking structure of virus RNA is essential for infec- 
tivity. 
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